Lundbeck

Danish pharmaceutical company

LUN Nasdaq Copenhagen ISIN DK0010287234 LEI 5493006R4KC2OI5D3470
Follow Lundbeck Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2026 DKK · IFRS
EPS, diluted -
Revenue by fiscal year
DKK 22B
DKK 24.6B
FY24 FY25

Source: ESEF annual reports · latest filing